Applications of chitosan and its derivatives in veterinary medicine

Chitin, Chitosan, Oligosaccharides and Their Derivatives: Biological Activities and Applications

Volumn , Issue , 2010, Pages 461-478

  Şenel, Sevda ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930423738     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/EBK1439816035     Document Type: Chapter

References (80)

1. Ahmed, I. and K. Kasraian. 2002. Pharmaceutical challenges in veterinary product development. Advanced Drug Delivery Reviews 54 (6):871-882.
2. Arca, Ç. H., M. Günbeyaz, and S. şenel. 2009. Chitosan-based systems for delivery of vaccine antigens. Expert Reviews of Vaccines 8 (7):937-953.
3. Berger, J., M. Reist, J. M. Mayer, O. Felt, N. A. Peppas, and R. Gurny. 2004. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics 57 (1):19-34.
4. Boucard, N., C. Viton, D. Agay, E. Mari, T. Roger, Y. Chancerelle, and A. Domard. 2007. The use of physical hydrogels of chitosan for skin regeneration following third-degree burns. Biomaterials 28 (24):3478-3488.
5. Bowman, K. and K. W. Leong. 2006. Chitosan nanoparticles for oral drug and gene delivery. International Journal of Nanomedicine 1 (2):117-128.
6. Çokçalişkan, C., R. N. Gürsoy, M. Alkan, F. Özyörük, and S. Şenel. 2007. Chitosan-based vaccine delivery system for immunization against the foot and mouth disease. In Advances in Chitin Science, S. Şenel, K. M. Vaarum, M. M. şumnu, and A. A. Hıncal (eds.), Alp Ofset, Ankara, Turkey, pp. 231-233.
7. Determan, A. S., J. H. Wilson, M. J. Kipper, M. J. Wannemuehler, and B. Narasimhan. 2006. Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations. Biomaterials 27 (17):3312-3320.
8. El-Din, A. N. M. N., L. Shkreta, B. G. Talbot, M. S. Diarra, and P. Lacasse. 2006. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus. Vaccine 24 (12):1997-2006.
9. European Pharmacopoeia, 6th edn. 2008. Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM). Exotic Dogs Web site. 2009 [cited June 9, 2009]. Available from http://exoticdogs.com/default.asp?lvlA=46&id=1379.
10. Florindo, H. F., S. Pandit, L. M. D. Goncalves, H. O. Alpar, and A. J. Almeida. 2008. Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine 26 (33):4168-4177.
11. Fukumoto, Y., H. Daimaru, and T. Matsumoto. 1995. Significance of clinical application of chitosan in zoo and wild animals. A. Wojtasz-Pajak, Z. S. Karnicki, M. M. Brzenski, P. J. Bykowski (eds.), Wirtschaftsverlag NW, Germany, pp. 402-407.
12. Garcia, P., M. J. Mines, K. S. Bower, J. Hill, J. Menon, E. Tremblay, and B. Smith. 2009. Robotic laser tissue welding of sclera using chitosan films. Lasers in Surgery and Medicine 41 (1):60-67.
13. Gavini, E., V. Sanna, C. Juliano, M. C. Bonferoni, and P. Giunchedi. 2002. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech 3 (3):E20.
14. Ghendon, Y., S. Markushin, G. Krivtsov, and I. Akopova. 2008. Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines. Archives of Virology 153 (5):831-837.
15. Gogev, S., K. de Fays, M. F. Versali, S. Gautier, and E. Thiry. 2004. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine 22 (15-16):1946-1953.
16. Gruet, P., P. Maincent, X. Berthelot, and V. Kaltsatos. 2001. Bovine mastitis and intramammary drug delivery: Review and perspectives. Advanced Drug Delivery Reviews 50 (3):245-259.
17. Guang Liu, W. and K. De Yao. 2002. Chitosan and its derivatives-a promising non-viral vector for gene transfection. Journal of Control Release 83 (1):1-11.
18. Günbeyaz, M., Ç. H. Arca, A. Özkul, and S. Şnel. 2009a. Chitosan based formulations for mucosal vaccination against Bovine Herpesvirus Type 1 (BoHV-1). In 36th Annual Meeting and Exposition of the Controlled Release Society. July 18-23, 2009, Copenhagen, Denmark.
19. Günbeyaz, M., A. R. F. Majarashin, A. Özkul, and S. Şenel. 2009b. Cellular uptake studies of chitosan based delivery systems developed for mucosal immunization against Bovine Herpesvirus Type 1 (BoHV-1). In 9th International Conference of the European Chitin Society. May 23-26, 2009, Venice, Italy.
20. Haerdi-Landerer, M. C., J. Habermacher, B. Wenger, M. M. Suter, and A. Steiner. 2009. Slow release antibiotics for treatment of septic arthritis in large animals. The Veterinary Journal.
21. Haig, D. M., D. Grant, D. Deane, I. Campbell, J. Thomson, C. Jepson, D. Buxton, and G. Russell. 2008. An immunization strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever. Vaccine 26 (35):4461-4468.
22. Hejazi, R. and M. Amiji. 2003. Chitosan-based gastrointestinal delivery systems. Journal of Controlled Release 89 (2):151-165.
23. Helander, I. M., E. L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller. 2001. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. International Journal of Food Microbiology 71 (2-3):235-244.
24. Hoemann, C. D., A. Chenite, J. Sun, M. Hurtig, A. Serreqi, Z. Lu, E. Rossomacha, and M. D. Buschmann. 2007. Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal. Journal of Biomedical Materials Research Part A 83A (2):521-529.
25. Illum, L., N. F. Farraj, and S. S. Davis. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharmaceutical Research 11 (8):1186-1189.
26. Ishihara, M. 2002. Photocrosslinkable chitosan hydrogel as a wound dressing and a biological adhesive. Trends in Glycoscience and Glycotechnology 14 (80):331-341.
27. Ishihara, M., K. Ono, F. Sato, K. Nakanishi, I. Saito, H. Yura, T. Matsui, H. Hattori, M. Fujita, M. Kikuchi, and A. Kurita. 2001. Acceleration of wound contraction and healing with a photocrosslinkable chitosan hydrogel. Wound Repair and Regeneration 9 (6):513-521.
28. Ishihara, M., K. Nakanishi, K. Ono, M. Sato, M. Kikuchi, Y. Saito, H. Yura, T. Matsui, H. Hattori, M. Uenoyama, and A. Kurita. 2002. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials 23 (3):833-840.
29. Issa, M. M., Köping-Höggaard, M., and Artursson, P. 2005. Chitosan and the mucosal delivery of biotechnology drugs. Drug Discovery Today: Technologies 2 (20):1-6.
30. Je, J. Y. and S. K. Kim. 2006. Antimicrobial action of novel chitin derivative. Biochimica Et Biophysica Acta- General Subjects 1760 (1):104-109.
31. Jiang, H. L., M. L. Kang, J. S. Quan, S. G. Kang, T. Akaike, H. S. Yoo, and C. S. Cho. 2008. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 29 (12):1931-1939.
32. Khor, E. and L.Y. Lim. 2003. Implantable applications of chitin and chitosan. Biomaterials 24 (13):2339-2349.
33. Kodiak Pet Products Web site. 2009 [cited June 2, 2009]. Available from http://www.kodiakpetproducts.com/rss.
34. Kojima, K., Y. Okamoto, K. Miyatake, Y. Tamai, Y. Shigemasa, and S. Minami. 2001. Optimum dose of chitin and chitosan for organization of non-woven fabric in the subcutaneous tissue. Carbohydrate Polymers 46 (3):235-239.
35. Lai, W. F. and M. C. Lin. 2009. Nucleic acid delivery with chitosan and its derivatives. Journal of Control Release 134 (3):158-68.
36. Lauto, A., J. Hook, M. Doran, F. Camacho, L. A. Poole-Warren, A. Avolio, and L. J. R. Foster. 2005. Chitosan adhesive for laser tissue repair: In vitro characterization. Lasers in Surgery and Medicine 36 (3):193-201.
37. Lee, J. W., J. H. Park, and J. R. Robinson. 2000. Bioadhesive-based dosage forms: The next generation. Journal of Pharmaceutical Sciences 89 (7):850-866.
38. Li, X. Y., L. J. Jin, J. E. Uzonna, S. Y. Li, J. J. Liu, H. Q. Li, Y. N. Lu, Y. H. Zhen, and Y. P. Xu. 2009. Chitosanalginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): In vivo evaluation in a pig model of enteric colibacillosis. Veterinary Immunology and Immunopathology 129 (1-2):132-136.
39. Liu, W. G. and K. De Yao. 2002. Chitosan and its derivatives—A promising non-viral vector for gene transfection. Journal of Controlled Release 83 (1):1-11.
40. Liu, H., Y. M. Du, X. H. Wang, and L. P. Sun. 2004. Chitosan kills bacteria through cell membrane damage. International Journal of Food Microbiology 95 (2):147-155.
41. Maxwell, S., S. Şenel, and S. McClure. 2006a. Chitosan for delivery of mucosal vaccines in ruminants. In 33rd Annual Meeting and Exposition of the Controlled Release Society. July 22-26, 2006, Vienna, Austria.
42. Maxwell, S., S. Şenel, and S. McClure. 2006b. Mucosal vaccination of sheep with heliotrine antigen. In 13th International Pharmaceutical Technology Symposium. September 9-11, 2006, Ankara, Turkey.
43. McClure, S. J. 2009. Mucosal delivery of native and recombinant protein vaccines against Trichostrongylus colubriformis. International Journal for Parasitology 39 (5):599-606.
44. Minagawa, T., Y. Okamura, Y. Shigemasa, S. Minami, and Y. Okamoto. 2007. Effects of molecular weight and deacetylation degree of chitin/chitosan on wound healing. Carbohydrate Polymers 67 (4):640-644.
45. Minami, S., Y. Okamoto, and T. Umemura. 1991. A case of canker in a draft horse. Japanese Journal of Equine Science 2:65-70.
46. Minami, S., Y. Okamoto, and A. Matsuhashi. 1992. Application of chitin and chitosan in large animal practice. In Advances in Chitin and Chitosan, P. A. Sandford., C. J. Brine, and J. P. Zikakis (eds.), Elsevier Science Publications, New York, pp. 61-69.
47. Muzzarelli, R. A. A. 2009. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydrate Polymers 76 (2):167-182.
48. Muzzarelli, R. A. A., P. Morganti, G. Morganti, P. Palombo, M. Palombo, G. Biagini, M. Mattioli Belmonte, F. Giantomassi, F. Orlandi, and C. Muzzarelli. 2007. Chitin nanofibrils/chitosan glycolate composites as wound medicaments. Carbohydrate Polymers 70 (3):274-284.
49. Nair, L. S. and C. T. Laurencin. 2007. Biodegradable polymers as biomaterials. Progress in Polymer Science 32 (8-9):762-798.
50. Okamoto, Y., S. Minami, and A. Matsuhashi. 1992. Application of chitin and chitosan in small animal practice. P. A. Sandford, C. J. Brine, and J. P. Zikakis (eds.), Elsevier Science Publications, London, U.K., pp. 70-78.
51. Okamoto, Y., L. Southwood, T. S. Stashak, R. W. Norrdin, A. W. Nelson, S. Minami, A. Matsuhashi, K. Kato, and Y. Shigemasa. 1997. Effect of chitin on nonwoven fabric implant in tendon healing. Carbohydrate Polymers 33 (1):33-38.
52. Ölmez, S. S., P. Korkusuz, H. Bilgili, and S. Şenel. 2007. Chitosan and alginate scaffolds for bone tissue regeneration. Pharmazie 62 (6):423-431.
53. Özmeriç, N., G. Özcan, C. M. Haytaç, E. E. Alaaddinoğlu, M. F. Sargon, and S. Şenel. 2000. Chitosan film enriched with an antioxidant agent, taurine, in fenestration defects. Journal of Biomedical Materials Research 51 (3):500-503.
54. Rabea, E. I., M. E.-T. Badawy, C. V. Stevens, G. Smagghe, and W. Steurbaut. 2003. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 4 (6):1457-1465.
55. Rafat, M., F. F. Li, P. Fagerholm, N. S. Lagali, M. A. Watsky, R. Munger, T. Matsuura, and M. Griffith. 2008. PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering. Biomaterials 29 (29):3960-3972.
56. Renbutsu, E., M. Okamura, T. Tsuka, Y. Okamoto, Y. Omura, and S. Minami. 2007. Clinical application of UV-curable chitosan derivative and synthetic resin complex to prevent postoperative pneumothorax in a feline diaphragmatic hernia. In Advances in Chitin Science Vol. X, K. M. Varum, S. Şenel, M. M. Şumnu, and A. A. Hıncal (eds.), Alp Ofset, Ankara, Turkey, pp. 413-416.
57. Sandri, G., S. Rossi, F. Ferrari, M. C. Bonferoni, C. Muzzarelli, and C. Caramella. 2004. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. European Journal of Pharmaceutical Sciences 21 (2-3):351-359.
58. Sayın, B. and S. Şenel. 2008. Chitosan and its derivatives for mucosal immunization. In Current Research and Development on Chitin in Biomaterial Science, R. Jayakumar and M. Prabaharan (eds.), Research Signpost, Kerala, India, pp. 145-165.
59. Sayın, B., S. Somavarapu, X. W. Li, M. Thanou, D. Sesardic, H. O. Alpar, and S. Şenel. 2008. Mono-Ncarboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. International Journal of Pharmaceutics 363 (1-2):139-148.
60. Schipper, N. G. M., S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. Varum, and P. Artursson. 1997. Chitosans as absorption enhancers for poorly absorbable drugs.2. Mechanism of absorption enhancement. Pharmaceutical Research 14 (7):923-929.
61. Şenel, S. and S. J. McClure. 2004. Potential applications of chitosan in veterinary medicine. Advanced Drug Delivery Reviews 56 (10):1467-1480.
62. Şenel, S., M. J. Kremer, S. KaŞ, P. W. Wertz, A. A. Hıncal, and C. A. Squier. 2000. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21 (20):2067-2071.
63. Seyfarth, F., S. Schliernann, P. Elsner, and U. C. Hipler. 2008. Antifungal effect of high- and low-molecularweight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-dglucosamine against Candida albicans, Candida krusei and Candida glabrata. International Journal of Pharmaceutics 353 (1-2):139-148.
64. Shi, C. M., Y. Zhu, X. Z. Ran, M. Wang, Y. P. Su, and T. M. Cheng. 2006. Therapeutic potential of chitosan and its derivatives in regenerative medicine. Journal of Surgical Research 133 (2):185-192.
65. Singla, A. K. and M. Chawla. 2001. Chitosan: Some pharmaceutical and biological aspects-an update. Journal of Pharmacy and Pharmacology 53 (8):1047-1067.
66. Sinha, V. R., A. K. Singla, S. Wadhawan, R. Kaushik, R. Kumria, K. Bansal, and S. Dhawan. 2004. Chitosan microspheres as a potential carrier for drugs. International Journal of Pharmaceutics 274 (1-2):1-33.
67. Talbot, B. G. and P. Lacasse. 2005. Progress in the development of mastitis vaccines. Livestock Production Science 98 (1-2):101-113.
68. Tian, J., J. Yu, and X. Sun. 2008. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunization of Japanese flounder (Paralichthys olivaceus). Veterinary Immunology and Immunopathology 126 (3-4):220-229.
69. Ueno, H., T. Mori, and T. Fujinaga. 2001. Topical formulations and wound healing applications of chitosan. Advanced Drug Delivery Reviews 52 (2):105-115.
70. Ueno, H., T. Ohya, H. Ito, Y. Kobayashi, K. Yamada, and M. Sato. 2007. Chitosan application to X-ray irradiated wound in dogs. Journal of Plastic, Reconstructive & Aesthetic Surgery 60 (3):304-310.
71. Vandamme, T. F. and K. J. Ellis. 2004. Issues and challenges in developing ruminal drug delivery systems. Advanced Drug Delivery Reviews 56 (10):1415-1436.
72. Vétoquinol Web site. 2009 [cited June 2, 2009]. Available from http://www.vetoquinolusa.com/pages/global_02.html.
73. Vila, A., A. Sanchez, K. Janes, I. Behrens, T. Kissel, J. L. V. Jato, and M. J. Alonso. 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. European Journal of Pharmaceutics and Biopharmaceutics 57 (1):123-131.
74. Vinsova, J. and E. Vavrikova. 2008. Recent advances in drugs and prodrugs design of chitosan. Current Pharmaceutical Design 14 (13):1311-1326.
75. Wang, S. H. and J. C. Chen. 2005. The protective effect of chitin and chitosan against Vibrio alginolyticus in white shrimp Litopenaeus vannamei. Fish & Shellfish Immunology 19 (3):191-204.
76. Whang, H. S., W. Kirsch, Y. H. Zhu, C. Z. Yang, and S. M. Hudson. 2005. Hemostatic agents derived from chitin and chitosan. Journal of Macromolecular Science-Polymer Reviews C45 (4):309-323.
77. Winzenburg, G., C. Schmidt, S. Fuchs, and T. Kissel. 2004. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Advanced Drug Delivery Reviews 56 (10):1453-1466.
78. Wisńiewska-Wrona, M., A. Niekraszewicz, H. Struszczyk, and K. Guziñska. 2002. Estimation of polymer compositions containing chitosan for veterinary applications. Fibers & Textiles in Eastern Europe 3 (38):82-85.
79. Xie, Z., H. Li, J. C. Chen, H. Zhang, Y. Wang, Q. Chen, Z. Zhao et al. 2007. Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine. Vaccine 25 (48):8163-8171.
80. Xie, H., J. S. Teach, A. P. Burke, L. D. Lucchesi, P. C. Wu, and R. C. Sarao. 2009. Laparoscopic repair of inferior vena caval injury using a chitosan-based hemostatic dressing. American Journal of Surgery 197 (4):510-514.